Geneva, Mar 12 (Prensa Latina) The World Health Organization (WHO) is reviewing reports on the suspension, in several countries, of the Covid-19 vaccine developed by AstraZeneca and the University of Oxford.
Austria, Estonia, Latvia, Lithuania, Luxembourg and Italy stopped using it, while Denmark, Thailand, Norway and Iceland suspended the immunization process with that vaccine.
These nations' decision were made due to reports on the formation of blood clots in people who were administered the vaccine.
That same batch was distributed in 17 countries, including Spain, where no such cases have been reported so far, only minor side effects.
WHO underlined that it is studying the situation of the vaccine developed by AstraZeneca and the Univeristy of Oxford, and the results will be published with their respective recommendations.
For its part, the pharmaceutical company insisted on the fact that the vaccine's safety was extensively studied in clinical trials in humans, and it was generally well assimilated.
There are reports of 30 such cases among five million people who were vaccinated until March 10.
However, Sweden confirmed that it will continue to use the AstraZeneca vaccine, as well as Finnland, whose authorities are closely monitoring its Scandinavian neighbors' decisions. France also supports the vaccine.
At present, four vaccines have been approved by the European Union. They are the ones developed by Pfizer/BioNTech, Moderna, AstraZeneca and Johnson&Johnson, RIA Novosti reported on Friday.
jg/aph/agp/joe
Austria, Estonia, Latvia, Lithuania, Luxembourg and Italy stopped using it, while Denmark, Thailand, Norway and Iceland suspended the immunization process with that vaccine.
These nations' decision were made due to reports on the formation of blood clots in people who were administered the vaccine.
That same batch was distributed in 17 countries, including Spain, where no such cases have been reported so far, only minor side effects.
WHO underlined that it is studying the situation of the vaccine developed by AstraZeneca and the Univeristy of Oxford, and the results will be published with their respective recommendations.
For its part, the pharmaceutical company insisted on the fact that the vaccine's safety was extensively studied in clinical trials in humans, and it was generally well assimilated.
There are reports of 30 such cases among five million people who were vaccinated until March 10.
However, Sweden confirmed that it will continue to use the AstraZeneca vaccine, as well as Finnland, whose authorities are closely monitoring its Scandinavian neighbors' decisions. France also supports the vaccine.
At present, four vaccines have been approved by the European Union. They are the ones developed by Pfizer/BioNTech, Moderna, AstraZeneca and Johnson&Johnson, RIA Novosti reported on Friday.
jg/aph/agp/joe
No comments:
Post a Comment